Skip to main content
Log in

New Mab CB.Hep-1 Purification Process Eliminates the Need for Pre-Chromatographic Purification. Stability Demonstrated Over 100 Purification Cycles

  • Full Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

This investigation sought to discover whether purification of monoclonal antibody CB.Hep-1 in ascitic fluid is possible by protein A–Sepharose affinity chromatography, for 100 runs, without pre-purification steps. Results showed that direct application of ascitic fluid to protein A–Sepharose increased monoclonal antibody recovery by 27% compared with the traditional process (control) after 100 runs. The purity of the monoclonal antibody was >95% and the cost of the purification was 15% less than that of the control process. In conclusion, monoclonal antibody CB.Hep-1 in ascitic fluid can be purified by chromatography on protein A–Sepharose, for 100 purification cycles, without the need for pre-purification steps.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Köhler G, Milstein C (1975) Nature 256:485–497

    Article  Google Scholar 

  2. Waldmann TA, Levy R, Coller BS (2000) Hematology 1:394–408

    Article  Google Scholar 

  3. Haughton AN, Scheinberg DA (2000) Nat Med 6:373–374

    Article  Google Scholar 

  4. Reichert JM (2003) Nat Rev Drug Discov 2:695–702

    Article  CAS  Google Scholar 

  5. Reichert JM, Pavlou (2004) Nat Rev Drug Discov 3:383–384

    Article  CAS  Google Scholar 

  6. Clark M (1997) Chem Immunol 65:88–110

    CAS  Google Scholar 

  7. Eliasson M, Andersson R, Olsson A, Wigzell H, Uhlen M (1989) J Immunol 142:575–581

    CAS  Google Scholar 

  8. Hardy E, Martínez E, Diago D, Díaz R, González D, Herrera L (2000) J Biotechnol 77:157–167

    Article  CAS  Google Scholar 

  9. Premstaller A, Oberacher H, Walcher W, Timperio A-M, Zolla L, Chervet J-P, Cavusoglu N, Van Dorsellaer A, Huber CG (2001) Anal Chem 73:2390–2396

    Article  CAS  Google Scholar 

  10. Mahn A, Asenjo JA (2005) Biotechnol Adv 23:359–368

    Article  CAS  Google Scholar 

  11. Burtonan SC, Harding DRK (2001) J Biochem Biophys Methods 49:275–287

    Article  Google Scholar 

  12. Hu W, Liu Z, Ji D, Xie H, Gong D, Li L (2006) J Nephrol 19:312–317

    CAS  Google Scholar 

  13. Blank GS, Zapata G, Fahrner R, Milton M, Yedinak C, Knudsen H, Schmelzer C (2001) Bioseparation 10:65–71

    Article  CAS  Google Scholar 

  14. Valdés R, Gómez L, Padilla S, Brito J, Reyes B, Álvarez T, Mendoza O, Herrera O, Ferro W, Pujol M, Leal V, Linares M, Hevia Y, García C, Mila L, García O, Sánchez R, Acosta A, Geada D, Paez R, Luis Vega J, Borroto C (2003) Biochem Biophys Res Commun 308(1):94–100

    Article  Google Scholar 

  15. Lowry OH, Rosenbrough NJ, Farr AL, Randal R (1951) J Biol Chem 193:265–275

    CAS  Google Scholar 

  16. Cossío MEF, Díaz T, Galván A, Valdés R, González E, Ayala M, Díaz J, Bestagno M, Burrone O, Gavilondo J (1997) J Biotechnol 56:69–80

    Article  Google Scholar 

  17. Laemmli UK (1970) Nature 227:680–685

    Article  CAS  Google Scholar 

  18. Valdés R, Ibarra N, Ruibal I, Beldarraín A, Noa E, Herrera N, Alemán R, Padilla S, Garcia J, Pérez M, Morales R, Chong E, Reyes B, Quiñones Y, Agraz A, Herrera L (2002) J Biotechnol 96:251–258

    Article  Google Scholar 

  19. Schwartz W, Judd D, Wysocki M, Guerrier L, Birck-Wilson E, Boschetti E (2001) J Chromatogr B 908:251–263

    Article  CAS  Google Scholar 

  20. Valdés R, Díaz T, Nieto A, García C, Pérez M, García J, Quiñones Y (1995) Biotecnol Apl 12(2):115–119

    Google Scholar 

Download references

Acknowledgments

The authors would like to thank to the Monoclonal Antibody Department of the Center for Genetic Engineering and Biotechnology for their contribution to this comparison study. The authors also gratefully acknowledge Mena Cayetana Ramos from ‘Salvador Allende’ hospital for her effort to make possible the publication of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eutimio G. Fernandez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valdés, R., Álvarez, T., Tamayo, A. et al. New Mab CB.Hep-1 Purification Process Eliminates the Need for Pre-Chromatographic Purification. Stability Demonstrated Over 100 Purification Cycles. Chroma 67, 923–927 (2008). https://doi.org/10.1365/s10337-008-0607-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-008-0607-5

Keywords

Navigation